Oral contraceptives and breast cancer

Area of Science:

• Oncology
• Epidemiology
• Pharmacology

Background:

• Oral contraceptives (OCs) are widely used by women of reproductive age.
• Previous studies on the association between OC use and breast cancer risk have yielded inconsistent results.
• Understanding the potential risks associated with long-term OC use is crucial for public health.

Purpose of the Study:

• To investigate the relationship between oral contraceptive use and the incidence of breast cancer.
• To determine if age modifies the association between oral contraceptive use and breast cancer risk.

Main Methods:

• A retrospective cohort study was conducted at Group Health Cooperative of Puget Sound.
• Computerized records of diagnoses and outpatient drug use were utilized to identify oral contraceptive users and non-users.
• Breast cancer incidence was compared between users and non-users, stratified by age groups.

Main Results:

• In women aged 45 years or younger, the incidence of breast cancer was similar for both oral contraceptive users and non-users.
• A positive association between current oral contraceptive use and breast cancer was observed in premenopausal women over 45.
• Specifically, women aged 46-50 years had a risk ratio of 4.0 (90% CI: 1.8-9.0), and women aged 51-55 years had a risk ratio of 15.5 (90% CI: 5.2-46).

Conclusions:

• Oral contraceptive use does not appear to increase breast cancer risk in younger women (≤45 years).
• Older premenopausal women (over 45 years) currently using oral contraceptives demonstrate a significantly elevated risk of breast cancer.
• These findings suggest an age-dependent risk associated with oral contraceptive use and breast cancer, warranting further investigation and consideration in clinical practice.